journal article·2023-01-31Open access

Acoustic Voice and Speech Biomarkers of Treatment Status during Hospitalization for Acute Decompensated Heart Failure

Olivia M. Murton, G. William Dec, Robert E. Hillman, Maulik D. Majmudar, Johannes Steiner, John V. Guttag, Daryush D. Mehta

Applied Sciences· Volume 13· Issue 3

Abstract

This study investigates acoustic voice and speech features as biomarkers for acute decompensated heart failure (ADHF), a serious escalation of heart failure symptoms including breathlessness and fatigue. ADHF-related systemic fluid accumulation in the lungs and laryngeal tissues is hypothesized to affect phonation and respiration for speech. A set of daily spoken recordings from 52 patients undergoing inpatient ADHF treatment was analyzed to identify voice and speech biomarkers for ADHF and to examine the trajectory of biomarkers during treatment. Results indicated that speakers produce more stable phonation, a more creaky voice, faster speech rates, and longer phrases after ADHF treatment compared to their pre-treatment voices. This project builds on work to develop a method of monitoring ADHF using speech biomarkers and presents a more detailed understanding of relevant voice and speech features.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Voice and Speech Disorders · Phonocardiography and Auscultation Techniques · Respiratory and Cough-Related Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Laryngeal Surgery and Voice Rehabilitation, Massachusetts General Hospital, Boston, MA 02114, USA

Speech and Hearing Bioscience and Technology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA

MGH Institute of Health Professions, Boston, MA 02129, USA

Institute for Heart, Vascular, and Stroke Care, Massachusetts General Hospital, Boston, MA 02114, USA

Department of Surgery, Harvard Medical School, Boston, MA 02115, USA

Biofourmis, Inc., Boston, MA 02110, USA

Division of Cardiovascular Medicine, Oregon Health & Science University, Portland, OR 97239, USA

Computer Science & Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

Funding

Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital · NIH National Heart, Lung, and Blood Institute · Voice Health Institute

References (49)

Show source-provided references
1. Trends in heart failure hospitalizations in the US from 2008 to 201810.1016/j.cardfail.2021.08.020 ↗
2. Incidence and prevalence of heart failure in elderly persons, 1994–200310.1001/archinternmed.2007.80 ↗
3. Epidemiology of heart failure10.1002/ejhf.1858 ↗
4. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1789–1858.
5. The pathophysiology of heart failure10.1016/j.carpath.2011.11.007 ↗
6. Acute decompensated heart failure: Contemporary medical management
7. Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment10.1038/s41569-020-0379-7 ↗
8. Rehospitalization for heart failure: Predict or prevent?10.1161/CIRCULATIONAHA.112.125435 ↗
9. The physics of small-amplitude oscillation of the vocal folds10.1121/1.395910 ↗
10. Phonation threshold pressure: A missing link in glottal aerodynamics10.1121/1.402928 ↗
11. The role of hydration in vocal fold physiology10.1097/MOO.0b013e3283393784 ↗
12. The effect of viscosity changes in the vocal folds on the range of oscillation10.1016/S0892-1997(88)80005-5 ↗
13. Biological mechanisms underlying voice changes due to dehydration10.1044/1092-4388(2002/021) ↗
14. Effect of hydration treatments on laryngeal nodules and polyps and related voice measures10.1016/S0892-1997(05)80317-0 ↗
15. The effect of hydration on voice quality in adults: A systematic review10.1016/j.jvoice.2017.10.001 ↗
16. Automated assessment of psychiatric disorders using speech: A systematic review10.1002/lio2.354 ↗
17. Recent innovations in voice assessment expected to impact the clinical management of voice disorders10.1044/persp2.SIG3.4 ↗
18. Using ambulatory voice monitoring to investigate common voice disorders: Research update10.3389/fbioe.2015.00155 ↗
19. Williamson, J.R., Quatieri, T.F., Helfer, B.S., Horwitz, R.L., Yu, B., and Mehta, D.D. (2013, January 21). Vocal biomarkers of depression based on motor incoordination. Proceedings of the Third International Audio/Visual Emotion Challenge (AVEC 2013), 21st ACM International Conference on Multimedia, Barcelona, Spain.10.1145/2512530.2512531 ↗
20. Voice characteristics in the progression of Parkinson’s disease10.1080/136828200410654 ↗
21. Advances in Parkinson’s Disease detection and assessment using voice and speech: A review of the articulatory and phonatory aspects10.1016/j.bspc.2021.102418 ↗
22. Bulbar and speech motor assessment in ALS: Challenges and future directions10.3109/21678421.2013.817585 ↗
23. Voice signal characteristics are independently associated with coronary artery disease10.1016/j.mayocp.2017.12.025 ↗
24. Sara, J.D.S., Maor, E., Borlaug, B., Lewis, B.R., Orbelo, D., Lerman, L.O., and Lerman, A. (2020). Non-invasive vocal biomarker is associated with pulmonary hypertension. PLoS ONE, 15.10.1371/journal.pone.0231441 ↗
25. Quatieri, T., Talkar, T., and Palmer, J. (2020). A framework for biomarkers of COVID-19 based on coordination of speech-production subsystems. IEEE Open J. Eng. Med. Biol., in press.10.1109/OJEMB.2020.2998051 ↗
26. Vocal biomarker is associated with hospitalization and mortality among heart failure patients10.1161/JAHA.119.013359 ↗
27. Remote speech analysis in the evaluation of hospitalized patients with acute decompensated heart failure10.1016/j.jchf.2021.08.008 ↗
28. Acoustic speech analysis of patients with decompensated heart failure: A pilot study10.1121/1.5007092 ↗
29. Gender differences in patients with heart failure10.1016/S1474-5151(03)00002-1 ↗
30. Sex differences in heart failure10.1093/eurheartj/ehz835 ↗
31. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting10.1016/S0735-1097(00)01156-6 ↗
32. Consensus auditory-perceptual evaluation of voice: Development of a standardized clinical protocol10.1044/1058-0360(2008/08-0017) ↗
33. Fairbanks, G. (1960). Voice and Articulation Drillbook, Harper and Row.
34. Relationships between vocal function measures derived from an acoustic microphone and a subglottal neck-surface accelerometer10.1109/TASLP.2016.2516647 ↗
35. (2017, February 22). Praat: Doing Phonetics by Computer, Available online: http://www.praat.org.
36. A method for automatic detection of vocal fry10.1109/TASL.2007.910791 ↗
37. Improved automatic detection of creak10.1016/j.csl.2012.11.002 ↗
38. Identifying a creak probability threshold for an irregular pitch period detection algorithm10.1121/1.5100911 ↗
39. Data-driven detection and analysis of the patterns of creaky voice10.1016/j.csl.2014.03.002 ↗
40. Recommended protocols for instrumental assessment of voice: American Speech-Language-Hearing Association Expert Panel to develop a protocol for instrumental assessment of vocal function10.1044/2018_AJSLP-17-0009 ↗
41. Quantifying dysphonia severity using a spectral/cepstral-based acoustic index: Comparisons with auditory-perceptual judgements from the CAPE-V10.3109/02699206.2010.492446 ↗
42. Regression shrinkage and selection via the Lasso10.1111/j.2517-6161.1996.tb02080.x ↗
43. Mobile voice health monitoring using a wearable accelerometer sensor and a smartphone platform10.1109/TBME.2012.2207896 ↗
44. New effect size rules of thumb10.22237/jmasm/1257035100 ↗
45. Effects of physiological aging on speaking and reading rates10.1016/0021-9924(83)90035-7 ↗
46. The interrelationship of measures related to vocal function, speech rate, and laryngeal appearance in elderly women10.1044/jshr.3202.323 ↗
47. Maximum phonation time in healthy older adults10.1016/j.jvoice.2010.10.002 ↗
48. Cepstral peak prominence values for clinical voice evaluation10.1044/2020_AJSLP-20-00001 ↗
49. Prevalence and causes of dysphonia in a large treatment-seeking population10.1002/lary.22426 ↗